Kiniksa Pharmaceuticals 401(K) Plan — Form 5500 plan (Kiniksa Pharmaceuticals Corp.)

Plain-English plan summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Kiniksa Pharmaceuticals 401(K) Plan is a benefit plan reported by Kiniksa Pharmaceuticals Corp. under EIN 47-4596717 and plan number 001. The latest loaded filing year is 2023. The filing reports 364 participants and $27,920,065 in end-of-year plan assets, where available in the loaded dataset.

Key reported metrics

Plan sponsor
Kiniksa Pharmaceuticals Corp.
EIN
47-4596717
Plan number
001
Plan type
2
Location
Lexington, MA
Latest filing year
2023
Participants
364
End-of-year plan assets
$27,920,065

Form 5500 filing history

Filings loaded for this plan
Filing yearParticipantsSchedulesFiling
2023364H, C20240709101922NAL0015244961001

Reported financial statement (2023 · Schedule H)

Net assets

Total assets (EOY)
$27,920,065
Total liabilities (EOY)
$0
Net assets (EOY)
$27,920,065
Net assets (BOY)
$18,681,351

Income & contributions

Employer contributions
$2,105,617
Participant contributions
$4,289,519
Total contributions
$7,053,817
Total income / additions
$11,145,867

Expenses & distributions

Benefits paid
$1,835,256
Administrative expenses
$69,187
Total expenses
$1,907,153
Net increase / (decrease)
$9,238,714

Service provider compensation (Schedule C)

Reported service provider compensation
ProviderServiceDirect comp.Indirect comp.Year
Fidelity Investments InstitutionalRECORDKEEPER$30,572not reported in the loaded dataset2023
Captrust Financial AdvisorsINVESTMENT ADVISOR$24,599not reported in the loaded dataset2023
Strategic Advisors, Inc.ADVISOR$10,614not reported in the loaded dataset2023

Related Form 5500 pages